Processa Pharmaceuticals, Inc. (PCSA)
NASDAQ: PCSA · Real-Time Price · USD
1.960
+0.060 (3.16%)
At close: Sep 18, 2026, 4:00 PM EDT
1.930
-0.030 (-1.53%)
After-hours: Sep 18, 2026, 7:30 PM EDT
Processa Pharmaceuticals Market Cap
Processa Pharmaceuticals has a market cap or net worth of $6.57 million as of September 18, 2026. Its market cap has decreased by -36.83% in one year.
Market Cap
6.57M
Enterprise Value
6.37M
1-Year Change
-36.83%
Ranking
Category
Stock Price
$1.96
ChartMarket Cap Chart
Since October 2, 2020, Processa Pharmaceuticals's market cap has decreased from $34.40M to $6.57M, a decrease of -80.90%. That is a compound annual growth rate of -24.24%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 5.50M | -15.38% |
| Dec 31, 2025 | 6.50M | 124.14% |
| Dec 31, 2024 | 2.90M | -64.63% |
| Dec 29, 2023 | 8.20M | -53.41% |
| Dec 30, 2022 | 17.60M | -77.14% |
| Dec 31, 2021 | 77.00M | 10.47% |
| Dec 31, 2020 | 69.70M | 102.62% |
| Oct 2, 2020 | 34.40M | - |
View and export this data all the way back to 2020. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ernexa Therapeutics | 6.14M |
| Kairos Pharma | 6.13M |
| Cardio Diagnostics Holdings | 6.07M |
| Creative Medical Technology Holdings | 5.78M |
| Xenetic Biosciences | 5.76M |
| NuCana | 5.73M |
| Lexaria Bioscience | 5.44M |
| Pulmatrix | 5.23M |